To validate our hypothesis that the anti-tumor efficacy of Lm-LLO-CD105A is related to the significant infiltration and polyfunctionality of cytotoxic CD8+ TILs, CD8 lymphocyte depletion experiments were carried out in both the subcutaneous and orthotopic RCC models. Here, CD8A is linked to renal cell carcinoma.